We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Digi International
DGII
$2.52B
| $225K | ﹤0.01% |
22,200
-28,100
| -56% | -$296K |
|
|
EXAC
802
DELISTED
Exactech Inc
EXAC
| $223K | ﹤0.01% |
9,899
-300
| -3% | -$6.96K |
|
803
Alaska Air
ALK
$5.15B
| $222K | ﹤0.01% |
4,760
-45,780
| -91% | -$1.9M |
|
804
REX American Resources
REX
$1.46B
| $222K | ﹤0.01% |
23,358
-40,284
| -63% | -$309K |
|
|
SYKE
805
DELISTED
SYKES Enterprises Inc
SYKE
| $222K | ﹤0.01% |
11,167
-100
| -0.9% | -$2.04K |
|
806
Inseego
INSG
$108M
| $221K | ﹤0.01% |
12,537
-10,970
| -47% | -$265K |
|
807
Cognizant
CTSH
$21.5B
| $220K | ﹤0.01% |
4,340
-271,160
| -98% | -$13.6M |
|
808
Build-A-Bear
BBW
$423M
| $217K | ﹤0.01% |
22,534
+7,503
| +50% | +$64.4K |
|
809
Universal Technical Institute
UTI
$2.08B
| $217K | ﹤0.01% |
+16,784
| New | +$221K |
|
|
POLY
810
DELISTED
Plantronics, Inc.
POLY
| $216K | ﹤0.01% |
4,870
-79,706
| -94% | -$3.52M |
|
|
CB
811
DELISTED
CHUBB CORPORATION
CB
| $215K | ﹤0.01% |
2,410
-153,610
| -98% | -$13.4M |
|
812
Usana Health Sciences
USNA
$394M
| $214K | ﹤0.01% |
+5,680
| New | +$198K |
|
813
Microvision
MVIS
$88.2M
| $212K | ﹤0.01% |
+109,800
| New | +$185K |
|
|
KBAL
814
DELISTED
Kimball International
KBAL
| $212K | ﹤0.01% |
14,988
-55,440
| -79% | -$731K |
|
|
HTWR
815
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $212K | ﹤0.01% |
+2,260
| New | +$220K |
|
|
AUXL
816
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $210K | ﹤0.01% |
7,730
-25,470
| -77% | -$676K |
|
817
HNI Corp
HNI
$3B
| $206K | ﹤0.01% |
5,640
-200
| -3% | -$7.14K |
|
818
Parker-Hannifin
PH
$125B
| $206K | ﹤0.01% |
+1,720
| New | +$206K |
|
|
SNV
819
DELISTED
Synovus
SNV
| $205K | ﹤0.01% |
+8,629
| New | +$210K |
|
|
ENZN
820
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
| $204K | ﹤0.01% |
198,536
-23,088
| -10% | -$23.8K |
|
|
LPDX
821
DELISTED
LIPOSCIENCE INC COM
LPDX
| $204K | ﹤0.01% |
+63,993
| New | +$269K |
|
|
PAMT
822
PAMT Corp
PAMT
$340M
| $203K | ﹤0.01% |
40,900
-19,600
| -32% | -$98.9K |
|
823
Codexis
CDXS
$135M
| $199K | ﹤0.01% |
97,563
+22,796
| +30% | +$41.6K |
|
824
Cumberland Pharmaceuticals
CPIX
$99M
| $198K | ﹤0.01% |
+44,010
| New | +$209K |
|
|
FGH
825
DELISTED
FG Group Holdings Inc.
FGH
| $196K | ﹤0.01% |
41,740
-10,939
| -21% | -$52.2K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.